National Pharmaceutical Council
Former Pharmaceutical Research & Manufacturers of America VP-Research & Information Services Gary Persinger joining NPC as VP to work on the council's value-of-pharmaceuticals research, particularly in the Medicaid and Medicare areas. NPC has initial results from its three-year project with Virginia Medicaid on the relationship between use of asthma medications and expenditures for emergency treatments. Persinger was part of the PhRMA economics group for 16 years
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth